Navigation Links
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
Date:3/26/2009

- First product approval from Sagent and Strides Arcolab Joint Venture -

SCHAUMBURG, Ill., March 26 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use. The Company anticipates the launch of azithromycin in April 2009. According to IMS, 2008 sales of azithromycin in the United States approximated $42 million.

"This approval marks an important milestone for Sagent, as azithromycin is the first product from our joint venture - established in 2007 - with Strides Arcolab," said Jeffrey M. Yordon, chief executive officer, founder, and chairman of the board of Sagent. "Strides' manufacturing and development expertise will be invaluable as we move forward with not only azithromycin, one of the world's most widely used antibiotics, but also with the more than 25 products under development by the joint venture."

Under the joint venture agreement, Sagent and Strides Arcolab are developing, supplying and marketing more than 25 injectable products for the U.S. market. Strides is responsible for developing and supplying injectable products that Sagent will market in the United States.

Since late 2007, Sagent launched eight products and currently has more than 70 Abbreviated New Drug Applications (ANDA) submissions on file with the U.S. FDA.

About Azithromycin

Azithromycin for injection is indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia due to Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophila'/>"/>

SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing
2. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
3. Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
4. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... French physician and gastronome Anthelme Brillat-Savarin understood the ... “Tell me what you eat, and I will tell ... stress or sadness has often been attributed to women, ... collected from their Emotional Eating Test reveals ... for different reasons. , Collecting data from 521 emotional ...
(Date:4/17/2015)... ERGO-Pedic Products, LLC, which produces therapeutic memory ... to help a broader range of people plagued by ... second most common visitors to doctors. , “The ERGO-Pedic ... help relieve sitting pain. Then, only a couple months ... customers later, we began getting questions from those customers, ...
(Date:4/17/2015)... “We have seen healing, a lot of ... present,” said Chaplain Shawn Kafader of Friendship Village. “People ... had anything to contribute have created beautiful pieces of art.” ... art therapy program that was launched to benefit residents of ... School of the Art Institute in Chicago, worked as an ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed Royce ... 1849 in congress on April 16, 2015 in an ... with the genetic disease. , The bill, similar ... first to create a federally led and financed initiative ... telangiectasia. This would effectively prevent premature death and disability ...
(Date:4/17/2015)... Most dental patients are not aware that ... overseas by foreign dental laboratories, according to the U.S. ... more than 40 states by their respective state boards ... Laboratories has created the “What’s In Your ... the consequences that could be associated with using poorly-made ...
Breaking Medicine News(10 mins):Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Healing At Friendship Village Due To Art Therapy 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:National Association Urges Transparency in Dental Industry 2
... System received extremely high ratings from dental professionals who were surveyed as ... Product Shopper. , ... Atlanta, GA (Vocus) March 24, 2009 -- The ... professionals who were surveyed as part of a product review published in ...
... Initiative founded by Dr. Ian Smith Reaches National MilestoneNEW YORK, ... 50 Million Pound Challenge has rallied more ... the pounds, not the fight., In doing so, those ... than 3.8 million pounds lost at 50millionpounds.com . "The ...
... Summer Relief! Woodward Laboratories adds a New Nail Fungus ... Treatment Line; Makes Diagnosing Nail Fungus Convenient and FreeALISO ... Americans have nail fungus, but only 2.5 million have ... Laboratories, a leading hand, foot and skin antimicrobial product ...
... Seattle-based organization facilitates blood transfusion services for major ... Wireless, a leading provider of mobile productivity and ... Private Network (VPN) solution has been deployed by ... mobile clinicians with access to wireless data and ...
... Day HARRISBURG, Pa., March 24 As diabetes rates ... stressed the need for Pennsylvanians to learn about steps they ... , , "While we don,t know the ... personal health choices can play a role in its development," ...
... greater investment in research to stem ,crippling, expenses , , ... report, the Alzheimer,s Association estimates that Alzheimer,s disease and ... In addition, people who live in nursing homes or ... out-of-pocket costs each year, researchers found. The association also ...
Cached Medicine News:Health News:KODAK 9000 3D Extraoral Imaging System Earns High Marks From Dental Professionals In Third Party Survey 2Health News:The 50 Million Pound Challenge Announces One-Millionth Member 2Health News:The 50 Million Pound Challenge Announces One-Millionth Member 3Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 2Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 3Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 3Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 4Health News:Control or Prevent Diabetes Through Healthier Habits, Pennsylvania Health Secretary Urges 2Health News:With Alzheimer's, Health-Care Costs Could Triple 2
(Date:4/17/2015)... -- ASSESS shows   plasma circulating tumour ... alternative to tumour biopsy   IGNITE supports ... NSCLC   AstraZeneca today presented results from two ... (ctDNA) testing for epidermal growth factor receptor (EGFR) mutation status ... (NSCLC) in clinical practice. [ 1 ] ...
(Date:4/17/2015)... DETROIT , April 17, 2015  In Detroit, where ... infant mortality rate is two and one half times of ... Nearly 6 of 10 infants that die in ... are sobering statistics that Covenant Community Care, a faith-based, charitable ... is poised to change thanks to a charitable donation by ...
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... "Medical Oxygen Systems - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Oxygen Systems in ... Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving ... US, Canada , Japan ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2
... for November 11, 2008 at 9:00 am ET, ... Anesiva,Inc. (Nasdaq: ANSV ) today announced that ... formulation of capsaicin, narrowly missed its,primary endpoint of ... at four to 32 hours post-surgery. The same,measure ...
... NOVATO, Calif., Nov. 10 Raptor,Pharmaceuticals Corp. ... today announced that the Company has entered ... d,Angers ("CHU d,Angers") of France to,evaluate Raptor,s ... Phase II clinical trial in patients with ...
Cached Medicine Technology:Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 2Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 3Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 4Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 2Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 3Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 4Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 6
... Easy to operate in a wide variety ... 121C(250F). • The manifold can be freely rotated ... position, yet always at an optimum angle towards ... geometry permits the use of most common pipette ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... Pipette is ideal for all liquid handling ... ergonomically-placed operating buttons, and various dispensing techniques ... diluting make this a lab favorite. It ... manual pipette without any adverse effects on ...
Medicine Products: